172 related articles for article (PubMed ID: 3130977)
1. Pure FSH induces ovulation in polycystic ovary syndrome despite rising androgen levels.
Traub AI; McFaul PB; Sheridan B; Leslie H
Clin Reprod Fertil; 1987 Aug; 5(4):167-71. PubMed ID: 3130977
[TBL] [Abstract][Full Text] [Related]
2. Ovulation induction with low doses of "pure" follicle stimulating hormone using a fixed protocol in patients with polycystic ovarian disease.
Bregieiro LO; de Moura MD; Ferriani RA; Bailão LA; de Sá MF
Int J Fertil Menopausal Stud; 1993; 38(3):152-9. PubMed ID: 8348163
[TBL] [Abstract][Full Text] [Related]
3. Ovulatory disorders in women with polycystic ovary syndrome.
Franks S; Adams J; Mason H; Polson D
Clin Obstet Gynaecol; 1985 Sep; 12(3):605-32. PubMed ID: 3933879
[TBL] [Abstract][Full Text] [Related]
4. Androgen response in polycystic ovarian syndrome to FSH treatment after LHRH agonist suppression.
Hamori M; Zwirner M; Clédon P; Tinneberg HR
Int J Fertil; 1992; 37(3):171-5. PubMed ID: 1355764
[TBL] [Abstract][Full Text] [Related]
5. Low-dose FSH stimulation in polycystic ovary syndrome: comparison of 3 FSH-preparations.
Strowitzki T; Seehaus D; Korell M; Hepp H
Exp Clin Endocrinol Diabetes; 1998; 106(5):435-9. PubMed ID: 9831312
[TBL] [Abstract][Full Text] [Related]
6. Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone?
Venturoli S; Paradisi R; Fabbri R; Porcu E; Orsini LF; Flamigni C
Int J Fertil; 1987; 32(1):66-70. PubMed ID: 2880819
[TBL] [Abstract][Full Text] [Related]
7. Predicting ongoing pregnancy following ovulation induction with recombinant FSH in women with polycystic ovary syndrome.
van Wely M; Bayram N; van der Veen F; Bossuyt PM
Hum Reprod; 2005 Jul; 20(7):1827-32. PubMed ID: 15831514
[TBL] [Abstract][Full Text] [Related]
8. Low-dose follicle stimulating hormone for ovulation induction in polycystic ovary syndrome.
Strowitzki T; Seehaus D; Korell M; Hepp H
J Reprod Med; 1994 Jul; 39(7):499-503. PubMed ID: 7966037
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation.
Artini PG; Monti M; Matteucci C; Valentino V; Cristello F; Genazzani AR
Gynecol Endocrinol; 2006 Aug; 22(8):465-70. PubMed ID: 17012110
[TBL] [Abstract][Full Text] [Related]
10. [Contribution of pure FSH in ovulation induction excluding fertilization in vitro].
Buvat J; Buvat-Herbaut M; Marcolin G; Verbecq P
Rev Fr Gynecol Obstet; 1991 Feb; 86(2):91-6. PubMed ID: 1905833
[TBL] [Abstract][Full Text] [Related]
11. Does plasma insulin level affect ovarian response to exogenous administration of follicle-stimulating hormone in women without polycystic ovary syndrome?
La Marca A; Pati M; Giulini S; Levratti P; Caretto S; Volpe A
Gynecol Endocrinol; 2005 Nov; 21(5):292-4. PubMed ID: 16373249
[TBL] [Abstract][Full Text] [Related]
12. Premature luteinization and ovulation induction using human menopausal gonadotrophin or pure follicle stimulating hormone in patients with polycystic ovary syndrome.
McFaul PB; Traub AI; Thompson W
Acta Eur Fertil; 1989; 20(3):157-61. PubMed ID: 2516391
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovarian disease.
Raj SG; Talbert LM
Obstet Gynecol Annu; 1984; 13():261-73. PubMed ID: 6232474
[TBL] [Abstract][Full Text] [Related]
14. [Chronic low dose follicle stimulating hormone step-up regimen in the treatment of polycystic ovary syndrome related anovulatory infertility with clomiphene resistance].
Chen W; Zhang Y; Dai Q
Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):588-90. PubMed ID: 11372406
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: relationships with chronological and ovarian age.
Palomba S; Falbo A; Orio F; Russo T; Sbano F; D'Alessandro P; Cariati F; Tolino A; Colao A; Zullo F
Gynecol Endocrinol; 2006 Jun; 22(6):329-35. PubMed ID: 16785158
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination.
Palomba S; Falbo A; Orio F; Manguso F; Russo T; Tolino A; Annamaria C; Dale B; Zullo F
Hum Reprod; 2005 Oct; 20(10):2879-86. PubMed ID: 15958399
[TBL] [Abstract][Full Text] [Related]
18. [Assisted reproduction strategy on polycystic ovarian syndrome].
Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2003 Aug; 38(8):484-6. PubMed ID: 14627036
[No Abstract] [Full Text] [Related]
19. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
20. ["Step protocols"].
Hugues JN
Contracept Fertil Sex; 1998 Apr; 26(4):307-11. PubMed ID: 9622966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
